These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 1823309)

  • 41. HLA/Bf haplotypes in a Newfoundland family.
    Larsen B; Pepper B; Barnard JM; Farid NR
    Tissue Antigens; 1978 Jul; 12(1):39-43. PubMed ID: 581240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. C4A gene deletion: association with Graves' disease.
    Ratanachaiyavong S; Lloyd L; McGregor AM
    J Mol Endocrinol; 1989 Sep; 3(2):145-53. PubMed ID: 2570594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA class II DNA genotypes in Graves' disease: clues to inheritance of the HLA-linked component of susceptibility.
    Fletcher J; Franklyn JA; McLachlan SM; Young E; Sheppard MC
    Clin Endocrinol (Oxf); 1988 Nov; 29(5):539-47. PubMed ID: 2908104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.
    Schleusener H; Schernthaner G; Mayr WR; Kotulla P; Bogner U; Finke R; Meinhold H; Koppenhagen K; Wenzel KW
    J Clin Endocrinol Metab; 1983 Apr; 56(4):781-5. PubMed ID: 6131902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HLA DR2 and DQ1 frequency among narcoleptic patients in Hong Kong Chinese.
    Wing YK; Chen CN; Ho CK
    Psychiatry Clin Neurosci; 1998 Oct; 52(5):523-7. PubMed ID: 10215015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Certain HLA alleles are associated with stress-triggered Graves' disease and influence its course.
    Vita R; Lapa D; Trimarchi F; Vita G; Fallahi P; Antonelli A; Benvenga S
    Endocrine; 2017 Jan; 55(1):93-100. PubMed ID: 26951052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of immunoglobulin A deficiency and elevated thyrotropin-receptor autoantibodies in two Nordic countries.
    Jorgensen GH; Ornolfsson AE; Johannesson A; Gudmundsson S; Janzi M; Wang N; Hammarström L; Ludviksson BR
    Hum Immunol; 2011 Feb; 72(2):166-72. PubMed ID: 20977916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MHC-extended haplotypes in families of patients with Graves' disease.
    Ratanachaiyavong S; Lloyd L; Darke C; McGregor AM
    Hum Immunol; 1993 Feb; 36(2):99-111. PubMed ID: 8096501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HLA-DQ3 is associated with Graves' disease in African-Americans.
    Ofosu MH; Dunston G; Henry L; Ware D; Cheatham W; Brembridge A; Brown C; Alarif L
    Immunol Invest; 1996; 25(1-2):103-10. PubMed ID: 8675226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations.
    Inoue D; Sato K; Enomoto T; Sugawa H; Maeda M; Inoko H; Tsuji K; Mori T; Imura H
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):75-82. PubMed ID: 1559302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Full-length DQ beta cDNA sequences of HLA-DR2/DQw1 subtypes: genetic interactions between two DQ beta loci generate human class II HLA diversity.
    Wu SK; Lu D; Madden M; Liu CP; Miyokawa N; Bach FH; Saunders TL
    Hum Immunol; 1990 Apr; 27(4):305-22. PubMed ID: 2318676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic factors in Graves' ophthalmopathy.
    Frecker M; Stenszky V; Balazs C; Kozma L; Kraszits E; Farid NR
    Clin Endocrinol (Oxf); 1986 Nov; 25(5):479-85. PubMed ID: 3113776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA class II associations in African-American female patients with Graves' disease.
    Yanagawa T; DeGroot LJ
    Thyroid; 1996 Feb; 6(1):37-9. PubMed ID: 8777382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406.
    Uchigata Y; Kuwata S; Tsushima T; Tokunaga K; Miyamoto M; Tsuchikawa K; Hirata Y; Juji T; Omori Y
    J Clin Endocrinol Metab; 1993 Jul; 77(1):249-54. PubMed ID: 8325948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HLA-DRB3 gene alleles in Caucasian patients with Graves' disease.
    Boehm BO; Kühnl P; Manfras BJ; Chen M; Lee JC; Holzberger G; Seidl S; Schifferdecker E; Schumm-Draeger PM; Usadel KH
    Clin Investig; 1992 Oct; 70(10):956-60. PubMed ID: 1450621
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HLA-DQB1 genotype in Sardinian multiple sclerosis: evidence for a key role of DQB1 *0201 and *0302 alleles.
    Marrosu MG; Muntoni F; Murru MR; Costa G; Pischedda MP; Pirastu M; Sotgiu S; Rosati G; Cianchetti C
    Neurology; 1992 Apr; 42(4):883-6. PubMed ID: 1565247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Positive and negative associations of distinct HLA-DR2 subtypes with ulcerative colitis (UC).
    De La Concha EG; Fernandez-Arquero M; Santa-Cruz S; Lopez-Nava G; Figueredo MA; Diaz-Rubio M; Garcia-Paredes J
    Clin Exp Immunol; 1997 Jun; 108(3):392-5. PubMed ID: 9182881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene Map of the HLA Region, Graves' Disease and Hashimoto Thyroiditis, and Hematopoietic Stem Cell Transplantation.
    Sasazuki T; Inoko H; Morishima S; Morishima Y
    Adv Immunol; 2016; 129():175-249. PubMed ID: 26791860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between HLA antigens and infectious agents in contributing towards the development of Graves' disease.
    Kraemer MH; Donadi EA; Tambascia MA; Magna LA; Prigenzi LS
    Immunol Invest; 1998; 27(1-2):17-29. PubMed ID: 9561915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The HLA-DQ associations with Graves' disease in Chinese children.
    Wong GW; Cheng SH; Dorman JS
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):493-5. PubMed ID: 10468909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.